Product Program year 2025 Source: CMS Open Payments

Hyqvia

Biological Immunology

NDC 0944-2510-02

Open in the dashboard

General payments

$2,718,081

27,213 payments

Research payments

$4,800,102

2,294 payments

Through program year 2025, $2,718,081 in general payments and $4,800,102 in research payments were reported against Hyqvia (Immunology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

14 rows
Year Kind Amount Payments
2025 General $582,360 8,905
2025 Research $559,978 44
2024 General $819,840 9,495
2024 Research $263,038 89
2023 General $289,340 3,117
2023 Research $360,571 68
2022 General $242,009 1,778
2022 Research $437,302 244
2021 General $59,283 1,709
2021 Research $748,009 304
2020 General $135,898 837
2020 Research $883,300 509
2019 General $589,352 1,372
2019 Research $1,547,904 1,036

Breakdown

Who paid General payments · program years 2019–2025
  1. Takeda Pharmaceuticals U.S.A., Inc. $2,128,729 25,841 payments
  2. Shire North American Group Inc $589,352 1,372 payments
Top recipients General payments · program year 2025
  1. Antoine Azar Allergy & Immunology · Baltimore, MD $77,214 13% · 78 payments
  2. Kourosh Rezania Neurology · Chicago, IL $28,659 5% · 20 payments
  3. Alexis Shaefer Neurology · Augusta, GA $22,677 4% · 44 payments
  4. Ajai Chari Hematology & Oncology · New York, NY $22,079 4% · 4 payments
  5. Perry Richardson Clinical Neurophysiology · Washington, DC $19,372 3% · 22 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Neurology Psychiatry & Neurology $228,026 40% · 1,196 practitioners
  2. Allergy & Immunology Internal Medicine $89,180 16% · 29 practitioners
  3. Allergy & Immunology $49,968 9% · 328 practitioners
  4. Nurse Practitioner, Family Nurse Practitioner $35,510 6% · 554 practitioners
  5. Clinical Neurophysiology Psychiatry & Neurology $31,981 6% · 29 practitioners

The top 5 of 107 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Maryland $81,062 14% · 79 recipients
  2. Florida $65,657 11% · 613 recipients
  3. New York $50,647 9% · 245 recipients
  4. Illinois $47,051 8% · 133 recipients
  5. Georgia $31,770 5% · 175 recipients

The top 5 of 51 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

Prescribed to Medicare patients

Part D · data year 2024

Part D claims

2,497

Prescriptions dispensed, refills included

Drug cost

$16,832,695

Paid at the pharmacy, in all

Prescribers

117

With 11 or more claims of it

Medicare Part D drugs matched to HYQVIA, 2024
Part D drug Name match Relative to the largest Prescribers Claims Drug cost
Hyqvia Igg/Hyaluronidase,recombinant Same name 117 2,497 $16,832,695

Matched to this product by name; CMS does not link its files to Open Payments, so a similar name can be a different strength, form or brand. Prescriber counts include only prescribers with 11 or more claims of the drug, because CMS publishes nothing below that. Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy; it does not include drugs given in a clinic or hospital, or patients with other insurance.

Largest prescribers

First 5 of 100 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Tidence Prince Allergy/ Immunology TN 122 $630,150 $44
Arye Rubinstein Allergy/ Immunology NY 74 $900,846 $251
Nilamben Patel Allergy/ Immunology FL 62 $385,991 $122
Malathi Bathija Allergy/ Immunology MI 61 $462,096 $88
Karthik Krishnan Allergy/ Immunology TN 60 $174,948 $82

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 100 with Patron

Given in the clinic

Part B · billing code
Medicare Part B billing codes matched to HYQVIA
Billing code Providers Services Paid by Medicare
Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin J1575 4 171,101 $2,298,570

Drugs given by a clinician are billed to Medicare Part B, not Part D. The product is tied to a billing code through the NDC on CMS's crosswalk, which was published for a later quarter than the payments, so a code that changed in between can be missed. Providers with fewer than 11 patients for the code are not published. Medicare's payment here is what it paid for the services, to the billing practice.

27,213 general · 2,294 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record